Assessment of response to treatment and follow-up in gastroenteropancreatic neuroendocrine neoplasms

F. Grimaldi; N. Fazio; R. Attanasio; A. Frasoldati; E. Papini; N. Cremonini; M.V. Davì; L. Funicelli; S. Massironi; F. Spada; V. Toscano; A. Versari; M. Zini; M. Falconi; K. Öberg

doi:10.2174/1871530318666171213145803

Assessment of response to treatment and follow-up in gastroenteropancreatic neuroendocrine neoplasms

F. Grimaldi, N. Fazio, R. Attanasio, A. Frasoldati, E. Papini, N. Cremonini, M.V. Davì, L. Funicelli, S. Massironi, F. Spada, V. Toscano, A. Versari, M. Zini, M. Falconi, K. Öberg

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	419-449
Number of pages	31
Journal	Endocrine, Metabolic and Immune Disorders - Drug Targets
Volume	18
Issue number	5
DOIs	https://doi.org/10.2174/1871530318666171213145803
Publication status	Published - 2018

Access to Document

10.2174/1871530318666171213145803

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85052220920&doi=10.2174%2f1871530318666171213145803&partnerID=40&md5=6f0b27f045f6c1e02d3c93a5204e3a49

Cite this

Grimaldi, F., Fazio, N., Attanasio, R., Frasoldati, A., Papini, E., Cremonini, N., Davì, M. V., Funicelli, L., Massironi, S., Spada, F., Toscano, V., Versari, A., Zini, M., Falconi, M., & Öberg, K. (2018). Assessment of response to treatment and follow-up in gastroenteropancreatic neuroendocrine neoplasms. Endocrine, Metabolic and Immune Disorders - Drug Targets, 18(5), 419-449. https://doi.org/10.2174/1871530318666171213145803

Assessment of response to treatment and follow-up in gastroenteropancreatic neuroendocrine neoplasms. / Grimaldi, F.; Fazio, N.; Attanasio, R.; Frasoldati, A.; Papini, E.; Cremonini, N.; Davì, M.V.; Funicelli, L.; Massironi, S.; Spada, F.; Toscano, V.; Versari, A.; Zini, M.; Falconi, M.; Öberg, K.

In: Endocrine, Metabolic and Immune Disorders - Drug Targets, Vol. 18, No. 5, 2018, p. 419-449.

Research output: Contribution to journal › Article › peer-review

Grimaldi, F, Fazio, N, Attanasio, R, Frasoldati, A, Papini, E, Cremonini, N, Davì, MV, Funicelli, L , Massironi, S , Spada, F, Toscano, V, Versari, A, Zini, M, Falconi, M & Öberg, K 2018, 'Assessment of response to treatment and follow-up in gastroenteropancreatic neuroendocrine neoplasms', Endocrine, Metabolic and Immune Disorders - Drug Targets, vol. 18, no. 5, pp. 419-449. https://doi.org/10.2174/1871530318666171213145803

Grimaldi, F. ; Fazio, N. ; Attanasio, R. ; Frasoldati, A. ; Papini, E. ; Cremonini, N. ; Davì, M.V. ; Funicelli, L. ; Massironi, S. ; Spada, F. ; Toscano, V. ; Versari, A. ; Zini, M. ; Falconi, M. ; Öberg, K. / Assessment of response to treatment and follow-up in gastroenteropancreatic neuroendocrine neoplasms. In: Endocrine, Metabolic and Immune Disorders - Drug Targets. 2018 ; Vol. 18, No. 5. pp. 419-449.

@article{a70d9a6075df4b2e9c31499855e8f6c3,

title = "Assessment of response to treatment and follow-up in gastroenteropancreatic neuroendocrine neoplasms",

author = "F. Grimaldi and N. Fazio and R. Attanasio and A. Frasoldati and E. Papini and N. Cremonini and M.V. Dav{\`i} and L. Funicelli and S. Massironi and F. Spada and V. Toscano and A. Versari and M. Zini and M. Falconi and K. {\"O}berg",

note = "Export Date: 8 January 2019",

year = "2018",

doi = "10.2174/1871530318666171213145803",

language = "English",

volume = "18",

pages = "419--449",

journal = "Endocrine, Metabolic and Immune Disorders - Drug Targets",

issn = "1871-5303",

publisher = "Bentham Science Publishers B.V.",

number = "5",

}

TY - JOUR

T1 - Assessment of response to treatment and follow-up in gastroenteropancreatic neuroendocrine neoplasms

AU - Grimaldi, F.

AU - Fazio, N.

AU - Attanasio, R.

AU - Frasoldati, A.

AU - Papini, E.

AU - Cremonini, N.

AU - Davì, M.V.

AU - Funicelli, L.

AU - Massironi, S.

AU - Spada, F.

AU - Toscano, V.

AU - Versari, A.

AU - Zini, M.

AU - Falconi, M.

AU - Öberg, K.

N1 - Export Date: 8 January 2019

PY - 2018

Y1 - 2018

U2 - 10.2174/1871530318666171213145803

DO - 10.2174/1871530318666171213145803

M3 - Article

VL - 18

SP - 419

EP - 449

JO - Endocrine, Metabolic and Immune Disorders - Drug Targets

JF - Endocrine, Metabolic and Immune Disorders - Drug Targets

SN - 1871-5303

IS - 5

ER -